Societe Des Produits Nestle S.a.

Adare Pharmaceuticals, Inc.

Aptalis Pharma Limited

Adare Pharmaceuticals S.r.l.

Christian Stollberg

Luigi Boltri

Giovanni Ortenzi

Giuseppe De Franza

Danilo Clementi

Flavio Fabiani

Giancarla Bianchi

The present invention is directed to a pharmaceutical composition or dosage form having a stable, low (diluted) digestive enzyme content comprising at least one digestive enzyme and at least one carrier, or a dosage form thereof. The invention is also directed to a process of preparation of the composition or the dosage form. In addition the invention is directed to the treatment and prevention of disorders or conditions associated with a digestive enzyme deficiency in a patient in need thereof, comprising administering to said patient a pharmaceutically acceptable amount of the composition having a stable low digestive enzyme content or dosage form thereof.

Stable low digestive enzyme content formulation

The present invention provides a microcapsule pharmaceutical composition of at least a bisquinoline drug. said microcapsule comprises a drug core of a pharmaceutically effective amount of a bisquinoline drug and a polymeric coating over the core. This microcapsule pharmaceutical composition has desirable pharmaceutical properties, including taste masking effect and a high stability.

Piperaquine microcapsules and compositions containing them

Growing community of inventors

Carugate, Italy

Christian Stollberg